Recurrent deletions of the TNFSF7 and TNFSF9 genes in 19p13.3 in diffuse large B‐cell and Burkitt lymphomas

A single nucleotide polymorphism‐chip analysis of 98 cases of aggressive B‐cell lymphomas revealed a recurrent deletion at 19p13 in nine of the cases. Six further cases with deletions encompassing this region were found in array‐comparative genomic hybridization data of 295 aggressive B‐cell lymphomas from a previous study. Three cases even showed a homozygous deletion, suggesting a tumor suppressor gene in the deleted region. Two genes encoding members of the tumor necrosis factor superfamily (TNFSF) were located in the minimally deleted region, that is, TNFSF7 and TNFSF9. As no mutations were found within the coding exons of the remaining alleles in the lymphomas with heterozygous deletions, we speculate that the deletions may mostly function through a haploinsufficiency mechanism. The cases with deletions encompassed both diffuse large B‐cell lymphomas and Burkitt lymphomas, and a deletion was also found in a Hodgkin lymphoma cell line. Thus, TNFSF7 and TNFSF9 deletions are recurrent genetic lesions in multiple types of human lymphomas.

[1]  A. Knudson,et al.  A continuum model for tumour suppression , 2011, Nature.

[2]  Raul Rabadan,et al.  Analysis of the Coding Genome of Diffuse Large B-Cell Lymphoma , 2011, Nature Genetics.

[3]  Dirk Hasenclever,et al.  Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults. , 2011, Blood.

[4]  J. Sweetenham Molecular signatures in the diagnosis and management of diffuse large B-cell lymphoma , 2011, Current opinion in hematology.

[5]  Mary Goldman,et al.  The UCSC Genome Browser database: update 2011 , 2010, Nucleic Acids Res..

[6]  R. Spang,et al.  Detection of genomic aberrations in molecularly defined Burkitt’s lymphoma by array-based, high resolution, single nucleotide polymorphism analysis , 2010, Haematologica.

[7]  J. Borst,et al.  Mice deficient for CD137 ligand are predisposed to develop germinal center-derived B-cell lymphoma. , 2009, Blood.

[8]  R. Spang,et al.  Microarray‐based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status , 2009, Genes, chromosomes & cancer.

[9]  A. Rosenwald,et al.  Molecular biology and genetics of lymphomas. , 2008, Hematology/oncology clinics of North America.

[10]  R. Siebert,et al.  Identification of candidate tumour suppressor gene loci for Hodgkin and Reed‐Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines , 2008, British journal of haematology.

[11]  R. Spang,et al.  Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. , 2008, Blood.

[12]  Tao Han,et al.  Assessing batch effects of genotype calling algorithm BRLMM for the Affymetrix GeneChip Human Mapping 500 K array set using 270 HapMap samples , 2008, BMC Bioinformatics.

[13]  C. Ziske,et al.  Prevention of lethal tumor growth and generation of long-lasting immunity in vivo using CD137L and interleukin-12 gene transfer. , 2008, In vivo.

[14]  D. Dolfi,et al.  Late Signals from CD27 Prevent Fas-Dependent Apoptosis of Primary CD8+ T Cells1 , 2008, The Journal of Immunology.

[15]  M Loeffler,et al.  Development and Implementation of an Analysis Tool for Array-based Comparative Genomic Hybridization , 2007, Methods of Information in Medicine.

[16]  D. Tough,et al.  Requirement for CD70 in CD4+ Th Cell-Dependent and Innate Receptor-Mediated CD8+ T Cell Priming1 , 2006, The Journal of Immunology.

[17]  R. Spang,et al.  A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. , 2006, The New England journal of medicine.

[18]  Terrence S. Furey,et al.  The UCSC Genome Browser Database: update 2006 , 2005, Nucleic Acids Res..

[19]  BRLMM : an Improved Genotype Calling Method for the GeneChip ® Human Mapping 500 K Array Set , 2006 .

[20]  P. Brossart,et al.  Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes , 2005, Cancer Gene Therapy.

[21]  Shigeru Chiba,et al.  A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. , 2005, Cancer research.

[22]  J. Bae,et al.  CD137-Deficient Mice Have Reduced NK/NKT Cell Numbers and Function, Are Resistant to Lipopolysaccharide-Induced Shock Syndromes, and Have Lower IL-4 Responses1 , 2004, The Journal of Immunology.

[23]  T. Schumacher,et al.  Tumor Rejection Induced by CD70-mediated Quantitative and Qualitative Effects on Effector CD8+ T Cell Formation , 2004, The Journal of experimental medicine.

[24]  A. Galy,et al.  4-1BB-ligand is regulated on human dendritic cells and induces the production of IL-12. , 2003, Cellular immunology.

[25]  Martin J S Dyer,et al.  Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci , 2002, International journal of cancer.

[26]  J. Aster,et al.  Molecular biology of Burkitt's lymphoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.